
brian lipworth
@doclip1
Followers
657
Following
4K
Media
263
Statuses
4K
Contrarian pulmonologist with an interest in airways disease and Head of Scottish Centre for Respiratory Research
Scotingland
Joined August 2011
Peripheral resistance (R5-R20) and compliance (AX) but not FEV1 differentiates between Dupilumab and Tezepelumab in severe uncotrolled asthma .
onlinelibrary.wiley.com
Click on the article title to read more.
1
5
11
Bronchodilator reversibility in severe asthma using spirometry and oscillometry ratios .Here we desribe using R5-R20 and X5/AX as small airways outcomes with reversibility testing .
onlinelibrary.wiley.com
Click on the article title to read more.
1
7
10
RT @AnnalsAllergy: If you are a Fellow-in-Training who has published a print article in Annals of Allergy, Asthma & Immunology between 7/1/….
college.acaai.org
The FIT Awards are for an original research or review paper written by a fellow-in-training (FIT) with the FIT as first or senior author.
0
2
0
No cigar for Astegolimab in COPD .15% overall reduction in both phase 3 studies .Need to see granular data for pts with Eos> 300/ul and FeNO>20 ppb in GOLD E subgroups .
roche.com
The pivotal phase IIb ALIENTO study met the primary endpoint of a statistically significant reduction in the annualised exacerbation rate (AER) at 52 weeks when astegolimab was given every two...
1
2
4